B6;129S2-Arsgtm1Tdi/Ieg

Status

Available to order

EMMA IDEM:13608
International strain nameB6;129S2-Arsgtm1Tdi/Ieg
Alternative nameArsgtm1Tdi
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolArsgtm1Tdi,
Gene/Transgene symbolArsg

Information from provider

ProviderTorben Lübke
Provider affiliationBiochemie, Chemistry, Bielefeld University
Genetic informationArsg (arylsulfatase G) is a protein coding gene. Diseases associated with Arsg include Usher Syndrome, Type IV and Usher Syndrome, Type IIIa. Among its related pathways are Metabolism of proteins and Metabolism. Gene Ontology (GO) annotations related to this gene include sulfuric ester hydrolase activity and arylsulfatase activity. An important paralog of this gene is Arsa. Mutation details: Exon 2 was disrupted by insertion of a neo cassette. RT-PCR confirmed the absence of mRNA expression in homozygous mice.
Phenotypic informationHomozygous:
Lysosomal storage and cellular alterations in the CNS of Arsg deficient mice; Arsg deficient mice accumulate heparan sulfate in visceral organs and the central nervous system and develop neuronal cell death and behavioral deficits demonstrating a critical role of Args in heparan sulfate degradation. Args deficiency represents a form of mucopolysaccharidosis, termed MPS IIIE.

Heterozygous:
No phenotype of heterozygous mice
Breeding historyGenerated in 129 derived ES cells and backcrossed to C57BL/6JRccHsd
References
  • Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.;Kowalewski Björn, Lamanna William C, Lawrence Roger, Damme Markus, Stroobants Stijn, Padva Michael, Kalus Ina, Frese Marc-André, Lübke Torben, Lüllmann-Rauch Renate, D'Hooge Rudi, Esko Jeffrey D, Dierks Thomas, ;2012;Proceedings of the National Academy of Sciences of the United States of America;109;10310-5; 22689975
  • Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).;Kowalewski Björn, Heimann Peter, Ortkras Theresa, Lüllmann-Rauch Renate, Sawada Tomo, Walkley Steven U, Dierks Thomas, Damme Markus, ;2015;Human molecular genetics;24;1856-68; 25452429
  • Degeneration of Photoreceptor Cells in Arylsulfatase G-Deficient Mice.;Kruszewski Katharina, Lüllmann-Rauch Renate, Dierks Thomas, Bartsch Udo, Damme Markus, ;2016;Investigative ophthalmology & visual science;57;1120-31; 26975023
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedno

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivinghomozygous C57BL/6J

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.;Kowalewski Björn, Lamanna William C, Lawrence Roger, Damme Markus, Stroobants Stijn, Padva Michael, Kalus Ina, Frese Marc-André, Lübke Torben, Lüllmann-Rauch Renate, D'Hooge Rudi, Esko Jeffrey D, Dierks Thomas, ;2012;Proceedings of the National Academy of Sciences of the United States of America;109;10310-5; 22689975
  • Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).;Kowalewski Björn, Heimann Peter, Ortkras Theresa, Lüllmann-Rauch Renate, Sawada Tomo, Walkley Steven U, Dierks Thomas, Damme Markus, ;2015;Human molecular genetics;24;1856-68; 25452429
  • Degeneration of Photoreceptor Cells in Arylsulfatase G-Deficient Mice.;Kruszewski Katharina, Lüllmann-Rauch Renate, Dierks Thomas, Bartsch Udo, Damme Markus, ;2016;Investigative ophthalmology & visual science;57;1120-31; 26975023

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).